Tech Center 3700 • Art Units: 3762 3766 3792 3796
This examiner grants 81% of resolved cases
Ankit D. Tejani is in Tech Center 3700 and Art Unit 3762. The examiner has 657 resolved cases and an allowance rate of 81.0 percent. The interview lift is 16.9 percent, indicating that interviews are helpful. Practitioners can use the interview process to clarify technical points and move toward a grant. The 81.0 percent allowance rate suggests a favorable environment for patent applicants in this art unit.
The median days to allowance is 877. This timeframe is efficient for the 657 cases processed in Art Unit 3762. The 81.0 percent allowance rate and the 877-day median pendency provide a clear expectation for the duration of the prosecution. Applicants can use the 16.9 percent interview lift to further improve their chances of success. With 657 cases resolved, the examiner has a well-documented history in Tech Center 3700. The 877-day timeline is a useful metric for managing client expectations.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18731766 | Systems, Devices, and Related Methods for Laser Lithotripsy | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18756675 | PERSONALIZED IMAGE-BASED GUIDANCE FOR ENERGY-BASED THERAPEUTIC DEVICES | Final Rejection | DJO, LLC |
| 18952201 | THERMAL SYSTEM WITH PATIENT SENSOR(S) | Non-Final OA | Stryker Corporation |
| 18209007 | DETECTING USER INFECTION USING WEARABLE SENSOR DATA | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18565062 | METHOD AND SYSTEM FOR QUALITY EVALUATION OF A SEQUENCE OF HEART INTERBEAT INTERVAL SIGNALS | Non-Final OA | Harman International Industries, Incorporated |
| 18264701 | RENAL NEUROMODULATION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18216236 | EYE TRACKING, PHYSIOLOGY, FACIAL EXPRESSION, AND POSTURE TO MODULATE EXPRESSION | Non-Final OA | Rockwell Collins, Inc. |
| 18697791 | Computer Implemented Method for Determining a Medical Parameter, Training Method and System | Final Rejection | BIOTRONIK SE & Co. KG |
| 18550361 | MEDICAL DEVICE FOR DETERMINING AN EXTREMUM OF A PERIODIC PHYSIOLOGIC SIGNAL | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18847424 | SYSTEM AND METHOD OF MONITORING NOCICEPTION AND ANALGESIA DURING ADMINISTRATION OF GENERAL ANESTHESIA | Non-Final OA | Massachusetts Institute of Technology |
| 18778217 | SYSTEMS AND METHODS FOR TREATING SLEEP DISORDERED BREATHING | Final Rejection | Vanderbilt University |
| 18840462 | LEAD EXTRACTION SYSTEM FOR RETAINED LEAD CONNECTORS | Non-Final OA | Medtronic, Inc. |
| 18784471 | SENSING CARDIAC SIGNALS WITH LEADS IMPLANTED IN EPIDURAL SPACE | Final Rejection | Medtronic, Inc. |
| 18446598 | STIMULATION PATTERNS FOR THERAPY | Non-Final OA | Medtronic, Inc. |
| 18392491 | SYSTEMS AND METHODS TO IMPROVE SLEEP DISORDERED BREATHING USING CLOSED-LOOP FEEDBACK | Final Rejection | The Cleveland Clinic Foundation |
| 17416449 | PROSTHESIS OPERATION IN THE FACE OF MAGNETIC FIELDS | Non-Final OA | Cochlear Limited |
| 18441756 | ELECTRONIC DEVICES, ELECTRODES THEREOF, AND METHODS FOR PRODUCING THE SAME | Final Rejection | Purdue Research Foundation |
| 18627153 | DYNAMIC VOLTAGE SCALING (DVS) IN PHOTOPLETHYSMOGRAPHY (PPG) SYSTEMS | Final Rejection | Analog Devices International Unlimited Company |
| 18536661 | BIOLOGICAL INFORMATION MEASURING APPARATUS AND BIOLOGICAL INFORMATION PROCESSING SYSTEM | Non-Final OA | OMRON HEALTHCARE CO., LTD. |
| 16702880 | LEADLESS IMPLANTABLE MEDICAL DEVICE WITH FIXATION ANTENNA MEMBER | Final Rejection | Pacesetter, Inc. |
| 18184405 | SENSORS AND METHODS FOR DETERMINING RESPIRATION | Non-Final OA | The Alfred E. Mann Foundation for Scientific Research |
| 18388192 | METHODS AND SYSTEMS OF IMPROVING AND MONITORING ADDICTION USING CUE REACTIVITY | Non-Final OA | West Virginia University Board of Governors on behalf of West Virginia University |
| 18955121 | IMPELLER AND FRAME FOR A BLOOD PUMP | Non-Final OA | MAGENTA MEDICAL LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy